Trial Outcomes & Findings for Clinical Performance Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens (NCT NCT04055519)

NCT ID: NCT04055519

Last Updated: 2021-05-13

Results Overview

Visual acuity (VA) was collected for each eye individually with study lenses in place at a distance of 4 meters using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

36 participants

Primary outcome timeframe

Day 30 after a minimum of 6 hours of wear, each product

Results posted on

2021-05-13

Participant Flow

Subjects were enrolled at 3 investigative sites located in the US.

This reporting group includes all randomized subjects/eyes (36/72) as treated. Note: Two subjects received investigational product misallocations and were exposed to the incorrect study product in the sequence.

Unit of analysis: eyes

Participant milestones

Participant milestones
Measure
LID017569, Then Biofinity
Lehfilcon A contact lenses worn in Period 1, with comfilcon A contact lenses worn in Period 2, as randomized. Each product was worn in both eyes on a daily wear basis at least 8 hours a day, 5 days a week, for 30 days. Lenses were removed nightly for cleaning and disinfection.
Biofinity, Then LID017569
Comfilcon A contact lenses worn in Period 1, with lehfilcon A contact lenses worn in Period 2, as randomized. Each product was worn in both eyes on a daily wear basis at least 8 hours a day, 5 days a week, for 30 days. Lenses were removed nightly for cleaning and disinfection.
First Wear Period (30 Days)
STARTED
16 32
20 40
First Wear Period (30 Days)
COMPLETED
16 32
20 40
First Wear Period (30 Days)
NOT COMPLETED
0 0
0 0
Second Wear Period (30 Days)
STARTED
16 32
20 40
Second Wear Period (30 Days)
COMPLETED
16 32
20 40
Second Wear Period (30 Days)
NOT COMPLETED
0 0
0 0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Clinical Performance Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Overall
n=36 Participants
LID017569 and Biofinity contact lenses worn during Period 1 and Period 2 in a crossover assignment, as randomized. Each product was worn in both eyes on a daily wear basis at least 8 hours a day, 5 days a week, for 30 days. Lenses were removed nightly for cleaning and disinfection.
Age, Continuous
34.1 years
STANDARD_DEVIATION 5.8 • n=5 Participants
Sex: Female, Male
Female
28 Participants
n=5 Participants
Sex: Female, Male
Male
8 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
35 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=5 Participants
Race (NIH/OMB)
White
34 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
36 participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 30 after a minimum of 6 hours of wear, each product

Population: This analysis population includes all subjects/eyes exposed to any study lenses evaluated in this study.

Visual acuity (VA) was collected for each eye individually with study lenses in place at a distance of 4 meters using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.

Outcome measures

Outcome measures
Measure
LID017569
n=72 eyes
Lehfilcon A contact lenses worn in both eyes on a daily wear basis at least 8 hours a day, 5 days a week, for 30 days. Lenses were removed nightly for cleaning and disinfection.
Biofinity
n=72 eyes
Comfilcon A contact lenses worn in both eyes on a daily wear basis at least 8 hours a day, 5 days a week, for 30 days. Lenses were removed nightly for cleaning and disinfection.
Distance VA (logMAR) With Study Lenses
-0.13 logMAR
Standard Deviation 0.06
-0.14 logMAR
Standard Deviation 0.06

Adverse Events

Pre-treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LID017569 Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LID017569 Nonocular/Systemic

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Biofinity Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Biofinity Nonocular/Systemic

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

CDMA Project Lead, Vision Care

Alcon Research, LLC

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
  • Publication restrictions are in place

Restriction type: OTHER